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Background: instrumental variable methods can estimate the causal 
effect of an exposure on an outcome using observational data. Many 
instrumental variable methods assume that the exposure–outcome 
relation is linear, but in practice this assumption is often in doubt, 
or perhaps the shape of the relation is a target for investigation. We 
investigate this issue in the context of Mendelian randomization, the 
use of genetic variants as instrumental variables.
Methods: Using simulations, we demonstrate the performance of a 
simple linear instrumental variable method when the true shape of 
the exposure–outcome relation is not linear. We also present a novel 
method for estimating the effect of the exposure on the outcome 
within strata of the exposure distribution. this enables the estima-
tion of localized average causal effects within quantile groups of the 
exposure or as a continuous function of the exposure using a sliding 
window approach.
Results: Our simulations suggest that linear instrumental variable 
estimates approximate a population-averaged causal effect. this is 
the average difference in the outcome if the exposure for every indi-
vidual in the population is increased by a fixed amount. estimates 
of localized average causal effects reveal the shape of the exposure–
outcome relation for a variety of models. these methods are used 
to investigate the relations between body mass index and a range of 
cardiovascular risk factors.
Conclusions: nonlinear exposure–outcome relations should not be a 
barrier to instrumental variable analyses. When the exposure–outcome 
relation is not linear, either a population-averaged causal effect or the 
shape of the exposure–outcome relation can be estimated.
(Epidemiology 2014;25: 877–885)
Most methods for estimating causal effects using instru-mental variables (iVs) make the assumption that the 
relation between the exposure and outcome is linear.1
although this may be approximately true in many cases, 
especially after transforming the exposure or outcome, in some 
situations, the exposure–outcome relation will be nonlinear. in 
this case, the shape of the relation may be a target for investiga-
tion. For example, the observed relation between body mass index 
(BMi) and mortality is highly nonlinear, with mortality increas-
ing sharply as BMi increases. However, an increased risk of 
mortality has also been observed for individuals with low BMi.2 
it is unclear whether this merely reflects reverse causation (sick 
people lose weight) or confounding (underweight individuals dif-
fer in other risk factors from those of average weight) or whether 
there is a causal effect of low BMi on increased mortality.3
in a randomized trial where the exposure is the treat-
ment received and the iV is treatment assignment, an iV anal-
ysis estimates a local average treatment effect.4,5
this is the average change in the outcome resulting from a 
change in the exposure among those patients for whom treatment 
assignment influences the treatment received. in a trial context, 
such patients are known as compliers, and the local average treat-
ment effect is also known as a complier-averaged causal effect.6 
consistency of the iV estimator is subject to the assumption that 
any effect of the iV on the exposure is in the same direction for all 
persons (known as the monotonicity assumption).
in an observational study, the iV and the exposure may 
be continuous rather than dichotomous. Here, the monotonicity 
assumption is that the exposure is a nondecreasing function of 
the iV for all persons (or, equivalently, a nonincreasing function 
for all persons). this is plausible in the context of Mendelian 
randomization—the use of genetic variants as iVs—because 
the biological effects of genetic variants are likely to be in the 
same direction in each person.7 the iV estimate can then be 
viewed as a weighted average of partial derivatives of the rela-
tion of the outcome with the exposure.8 in the discrete case, 
these derivatives can be interpreted as local average treatment 
effects at different values of the exposure and the iV.
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in this study, we explore the implications of nonlinear 
exposure–outcome relations for iV analyses, particularly in the 
context of Mendelian randomization. We initially consider the 
consequences of using linear iV models to estimate the effect 
of an exposure on an outcome when the true causal relation is 
nonlinear. We then introduce a novel approach for estimating 
localized average causal effects, which are iV estimates (local 
average treatment effects) estimated for strata of the population 
defined by the value of the exposure. these can provide evi-
dence of a nonlinear effect of the exposure on the outcome. We 
discuss the findings and implications of our results and com-
pare the approach introduced in this study with other paramet-
ric and nonparametric approaches to nonlinear iV analysis. We 
assume that the exposure and outcome are continuous; issues 
relating to binary outcomes are reserved for the discussion.
this study is illustrated using data on 8090 subcohort 
participants from the multicenter case-cohort study european 
Prospective investigation into cancer and nutrition (ePic)-
interact, the diabetes-focused component of the ePic.9 We use 
data on BMi (kg/m2) and a range of cardiovascular risk factors: 
systolic blood pressure (mmHg), c-reactive protein (mg/l, log-
transformed), uric acid (μmol/l), glycated hemoglobin (Hba1c, 
%), total cholesterol (mmol/l), and triglycerides (mmol/l, log-
transformed). increases in BMi have been shown to have causal 
effects on each of these factors in previous Mendelian random-
ization studies.10–12 the observational association of each of the 
risk factors with BMi in a linear regression model, and with 
BMi and BMi-squared in a quadratic regression model, is given 
in table 1. (BMi is centered before analysis, adjustment is made 
for age, sex, and center.) the mean levels and 95% confidence 
intervals (cis) of the risk factors for each quintile of BMi are 
shown in Figure 1. the observational relations of BMi with sev-
eral of the risk factors are nonlinear, although this does not nec-
essarily imply that the causal relations will be nonlinear.
LINEAR INSTRUMENTAL VARIABLE ANALYSIS 
WITH NONLINEAR RELATIONS
it has been suggested that the use of linear models 
for iV analysis may have some value even if the underlying 
exposure–outcome model is nonlinear.13 We here perform a 
simulation study to investigate the interpretation of linear iV 
estimates of nonlinear relations.
Simulation Study
We simulated data for 4000 persons on an iV G, a contin-
uous exposure X taking positive values, a continuous outcome 
Y, and a confounder U. Five shapes of causal relation were con-
sidered between X and Y: a linear relation, a quadratic relation, 
a J-shaped relation (persons with lower levels of the exposure 
have slightly increased average outcomes), a U-shaped rela-
tion (persons with lower levels of the exposure have consid-
erably increased average outcomes), and a threshold relation. 
graphs showing the nonlinear relations between the exposure 
and mean level of the outcome are given in Figure 2.
the data-generating model for individual i is:
x g ui i i Xi= + +0 25. ε  (1)
y f x ui j i i Yi= + +( ) .0 8 ε
gi ∼ Binomial  ( , . )2 0 3
ε Xi ∼ exponential(1)
ui ∼ Uniform 1( , )0
εYi N∼ ( , )0 1  independently
where fj (xi) is the function associating the exposure and outcome:
f x xi i1 0 4( ) .  (linear relation)=
f x xi i2
20 1( ) .  (quadratic relation)=
f x xi i3
20 2 1( ) . ( )  (J-shaped relation)= −
f x xi i4
20 3 2( ) . ( )  (U-shaped relation)= −




Linear Model Quadratic Model
BMI Coefficient (SE) BMI Coefficient (SE) BMI-squared Coefficient (SE)
Systolic BP 0.977 (0.055) 1.039 (0.060) −0.018 (0.007)
log crPa 9.172 (0.290) 9.255 (0.327) −0.021 (0.038)
Uric acid 4.972 (0.190) 5.253 (0.213) −0.071 (0.025)
Hba1ca 2.842 (0.201) 2.402 (0.225) 0.114 (0.026)
total cholesterola 1.997 (0.314) 2.981 (0.353) −0.248 (0.041)
log triglyceridesa 3.445 (0.141) 4.034 (0.158) −0.148 (0.018)
BMi is centered prior to analysis, and adjustment is made for age, sex, and center.
BMi indicates body mass index; BP, blood pressure; crP, c-reactive protein; Hba1c, glycated hemoglobin; Se, standard error.
acoefficients and standard errors are multiplied by 100 for presentation.
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the distribution of the iV (G = 0, 1, 2) was chosen to 
represent the number of variant alleles for a single nucleotide 
polymorphism with minor allele frequency 0.3. the distri-
bution of the exposure was simulated as positively skewed, 
with increased values corresponding to greater values of the 
outcome being less common (95th percentile: 3.7). the iV 
explained on average 2.4% of the variance in the exposure 
corresponding to an average F statistic of 49.6. these simu-
lations are repeated in the eappendix (http://links.lww.com/
eDe/a818), altering the data-generating model to allow the 
effect of the iV on the exposure to vary among individuals 
and the effect of the exposure on the outcome to vary among 
individuals.
For each of 10,000 simulated data sets, we calculated 
the ratio iV estimate (also called the Wald estimate) for the 
causal effect of the exposure on the outcome.14 this is calcu-
lated as the coefficient for the association of the iV with the 
outcome divided by the coefficient for the association of the 
iV with the exposure. For functions f2 to f5, the effect of a fixed 
increase in the exposure differs across the distribution of the 
exposure. therefore, we considered the average effects on the 
outcome of 2 interventions in the exposure: first, to increase 
the exposure for every individual by 1 unit; and second, to 
increase the exposure in every individual in the population by 
0.25 units (the effect of a unit increase in the iV on the expo-
sure). these quantities have been called population-averaged 
causal effects15 or average partial effects,16 as they average not 
only across individuals but also across the distribution of the 
exposure. as the data are simulated, the corresponding out-
comes at these counterfactual values of the exposure can be 
calculated for each individual person.
Results
We present the mean values across simulations of the 
ratio iV estimate for a 1-unit increase in the exposure, a scaled 
ratio estimate for a 0.25-unit increase in the exposure, and the 
mean values of the average changes in the outcome (popula-
tion-averaged causal effects) for 1-unit and 0.25-unit increases 
in the exposure (table 2). Similar results were observed when 
the effects of the iV on the exposure and of the exposure on the 
outcome were allowed to vary among individual persons (eap-
pendix, etables 1, 3, and 5, http://links.lww.com/eDe/a818).
in the linear case, the ratio estimates scaled to a 1-unit 
and a 0.25-unit increase in the exposure were both equal to 
the corresponding population-averaged causal effect. in the 
nonlinear cases, the population-averaged causal effect was 
similar to the ratio estimate for a 0.25-unit increase but was 
considerably different for a 1-unit increase. this difference is 
especially apparent for the U-shaped relation, where a 0.25-
unit increase in the exposure led to a fall in the average level 
of the outcome, but a 1-unit increase led to a rise. although 
the approximate equality may not hold for extreme shapes of 
the exposure–outcome relation, in the examples presented, the 
ratio iV estimate is close to the population-averaged causal 
effect for an increase in the exposure distribution of similar 
size to that associated with a change in the iV if the increase 
is small. We provide a theoretical motivation for this finding 
in the eappendix (http://links.lww.com/eDe/a818). Previous 
























































































































Quintiles of body mass index (kg/m²)
FIGURE 1. Mean level of cardiovascular risk  factors stratified 
by quintile of body mass  index against mean value of body 
mass index in quintile (lines are ±1.96 standard errors).






















































FIGURE 2. Nonlinear  relationships  between  exposure  and 
outcome  for  quadratic,  J-shaped,  U-shaped,  and  threshold 
relationship models.
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theoretical results have been derived relating the linear iV 
estimate to a weighted average of derivatives8; this finding 
is similarly motivated, but the interpretation as a population-
averaged causal effect is likely to be more familiar to an audi-
ence of applied researchers.
in general, the population-averaged causal effect cannot 
be generalized to the effect of an increase in the exposure for 
an individual.17 even in the linear case, under heterogeneity in 
the exposure–outcome model, the ratio estimate represents an 
average causal effect across the population.18 in the nonlinear 
case (such as with the threshold relation), a large proportion of 
the population will have no increase in the outcome associated 
with a small increase in the exposure, as the increased expo-
sure will not exceed the threshold level. With the J-shaped and 
U-shaped relations, a small increase in the exposure will lead 
to increases in the outcome for some persons and decreases 
for others.
POSSIBLE APPROACHES TO NONLINEAR 
INSTRUMENTAL VARIABLE ANALYSIS
although in some cases ignoring any nonlinearity in the 
exposure–outcome relation and estimating a population-aver-
aged causal effect may be sufficient, doing so does not give the 
investigator any insight into the shape of the relation. We dis-
cuss why standard iV approaches are not generally useful for 
investigating the shape of nonlinear relations, and we introduce 
a novel method for the estimation of localized average causal 
effects at different levels of the exposure distribution.
Unsuitability of Instrumental Variable 
Approaches for Estimating Nonlinear Relations
When values across the range of the distribution of 
BMi are compared, there is heterogeneity in the association 
between BMi and mortality. For example, in an observational 
setting, comparisons are commonly made and nonlinearities 
observed between groups of persons with BMi (kg/m2) in the 
ranges below 18.5 (underweight), 18.5 to 25 (normal weight), 
25 to 30 (overweight), and over 30 (obese). in contrast, taking 
the genetic variant with the greatest association with BMi in 
the ePic-interact data set (rs1421085, a variant in the FTO 
gene, R2 = 0.39%), persons with no BMi-increasing alleles 
(major homozygotes) have an average BMi of 26.3, those 
with 1 allele (heterozygotes) an average BMi of 26.7, and 
those with 2 alleles (minor homozygotes) an average BMi of 
27.1 (Figure 3). thus, although an observational analysis can 
compare groups of persons with nonoverlapping distributions 
of BMi and marked differences in their average BMi values 
(standard deviation of BMi = 4.33), a standard iV analysis 
using rs1421085 compares groups of persons with overlap-
ping distributions of BMi and slight differences in their aver-
age BMi values (standard deviation of fitted values of BMi 
conditional on iV = 0.26).
although approaches have been proposed for nonlin-
ear iV analysis,19–22 information for estimating the effect of 
the exposure on the outcome is available (without additional 
assumptions) only for predicted values of exposure based on 
the iV. nonlinearity for this reduced range of the exposure dis-
tribution is unlikely to be observed. Moreover, this range does 
not increase as the sample size increases. the shape of the 
relation outside this range can be estimated by the specifica-
tion of a parametric model for the exposure–outcome relation; 
however, inference based on such models has been shown to 
be highly sensitive to the choice of parametrization.16,22 We 
consider these issues further in relation to specific nonpara-
metric iV methods in the discussion.
Stratification of the Exposure and Localized 
Average Causal Effects
rather than estimating a population-averaged causal 
effect, we may wish to estimate an average causal effect for a 
stratum of the exposure distribution. these localized average 
causal effects will be constant in expectation if the relation is 
linear but will give insight into the shape of the exposure–out-
come relation if it is nonlinear. as the iV is associated with the 
exposure, by stratifying on the exposure distribution, an asso-
ciation between the iV and outcome may be induced even if 
this was not present in the original data.23 this can be avoided 
by stratifying based on the residual variation in the exposure 
conditional on the iV. Under the assumption that there is no 
heterogeneity in the average effect of the iV on the exposure at 
different levels of the exposure, this is equivalent to subtract-




Ratio Estimate Population-averaged Causal Effect
1-unit Mean (SD) 0.25-unit Mean (SD) 1-unit Mean (SD) 0.25-unit Mean (SD)
linear 0.400 (0.100) 0.100 (0.025)  0.400 (0.000)  0.100 (0.000)
Quadratic  0.338 (0.104)  0.084 (0.026)  0.430 (0.003)  0.089 (0.001)
J-shaped  0.276 (0.116)  0.069 (0.029)  0.460 (0.007)  0.077 (0.002)
U-shaped  −0.187 (0.134)  −0.047 (0.033)  0.090 (0.010)  −0.034 (0.002)
threshold  0.283 (0.110)  0.071 (0.028)  0.467 (0.007)  0.078 (0.002)
SD indicates standard deviation.
Epidemiology  •  Volume 25, Number 6, November 2014 Nonlinear Instrumental Variable Analysis
© 2014 Lippincott Williams & Wilkins  www.epidem.com  |  881
individuals based on their iV-free exposure level. the iV-free 
exposure level represents the expected value of the exposure, 
which would be observed if a person’s iV value was zero. 
although the iV-free exposure may appear to have a counter-
factual interpretation, it is not intended to be a counterfactual 
variable. rather, it is a function of the observed data. a coun-
terfactual interpretation would require the stronger assump-
tion that the effect of the iV on the exposure was constant for 
all individuals and is only necessary for the variable that is 
contrasted in the causal effect and not for the iV-free exposure 
that takes the role of a stratifying covariate.
Using the same simulated data sets as in the previous 
section, we stratified individuals based on their iV-free expo-
sure using categories below 1, 1 to 2, 2 to 3, and above 3. 
For each of these groups, we estimated the (stratum-specific) 
localized average causal effect of the exposure on the outcome 
using the ratio method (the association of the iV with the out-
come in the stratum divided by the association of the iV with 
the exposure in the population). the iV-free exposure was cal-
culated based on the estimated value of the association of the 
iV with the exposure in the whole population. table 3 shows 
that the true shape of the exposure–outcome relation is appar-
ent from comparing the mean values of these effects across 
the simulated data sets.
We emphasize the importance of stratifying based on 
the iV-free exposure; when the same effects were estimated 
across strata of the exposure without prior subtraction of the 
effect of the iV, in the linear case, the corresponding estimates 
were −0.150, −0.052, −0.001, and −0.003. in the directed acy-
clic graph of Figure 4, conditioning on the exposure X induces 
an association between G and U, which are both parents of X 
(termed moralization). in contrast, conditioning on the iV-free 
exposure X0 = X − αGG does not induce such an association.
We calculated cochran’s Q statistic to examine pos-
sible heterogeneity in the 4 estimates. this nonparametric 
test assesses whether differences between the estimates in the 
strata are more different than would be expected by chance. 
We also conducted a trend test by performing a meta-regres-
sion of the estimates on the mean values of the exposure in 
each stratum. this is a form of weighted regression where the 
variance of each value of the response variable is assumed to 
be known.24 the proportions of data sets where the cochran’s 
Q test rejected the null hypothesis (P < 0.05) were as follows: 
linear 5.2%, quadratic 25.2%, J-shaped 67.0%, U-shaped 
94.7%, and threshold 85.8%. the same proportions for the 
trend test were linear 4.1%, quadratic 31.8%, J-shaped 73.9%, 
U-shaped 94.7%, and threshold 65.6%. Similar results were 
observed when the effects of the iV on the exposure and of 
the exposure on the outcome were allowed to vary among per-
sons provided that the effect heterogeneities in the iV–expo-
sure and exposure–outcome associations were not correlated 
(eappendix, etables 2, 4, 6, and 7, http://links.lww.com/eDe/
a818). We conclude, based on this simulation example, that 
the heterogeneity and trend tests are at least sometimes able 
to detect nonlinearities in causal relations. the trend test has 
greater empirical power to detect nonlinearities, except for in 
the case of the threshold relation.
a generalization of this approach is to estimate the 
localized average causal effect across the distribution of the 
iV-free exposure using a sliding window. this is performed by 
first ordering individuals according to their iV-free exposure. 
Using an example window size of 1,000, the localized average 
causal effect is estimated for the first 1000 people, then for the 
individuals numbered 2 through to 1,001, then 3 to 1,002, and 
so on. the estimates can then be plotted against the median 
exposure value for each window. the range of the exposure 
distribution over which the localized average causal effect is 
estimated depends on the window size; however, for a fixed 
window size, the range expands as the sample increases. in the 
next section, we explore the impact of the choice of how wide 
to make the sliding window in a real data example.
APPLIED EXAMPLE: EFFECT OF BODY MASS 
INDEX ON CARDIOVASCULAR RISK FACTORS
in this section, we apply the linear and localized iV 
methods to the ePic-interact data set for the cardiovascu-
lar risk factors previously listed. Data were available on 29 
genetic variants previously shown to be associated with BMi 
in a large meta-analysis.25 Details of the variants are given 
in the eappendix (http://links.lww.com/eDe/a818) and their 
plausibility as iVs assessed by overidentification tests in each 
center (etable 8, http://links.lww.com/eDe/a818). an allele 
score comprising all the variants weighted by their reported 
association with BMi in the meta-analysis is used as an iV.26 
if an individual i has gik copies of variant allele k, that person’s 
allele score is k k ikw g∑ , where wk is the weight of the kth 
variant. the score explains 0.77% of the variance in BMi.
For each outcome, we fit a linear iV model using 
the ratio method, adjusting for age, sex, and center in the 


















FIGURE 3. Distribution  of  body  mass  index  in  subgroups 
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regressions of the outcome on the allele score and of the 
exposure on the allele score. We estimated the localized aver-
age causal effects of BMi on each risk factor within quin-
tiles of the distribution of BMi after the genetic component 
is subtracted (the iV-free BMi) and performed heterogeneity 
and trend tests on these values (table 4). to account for the 
multiple centers, we standardized the BMi measure used to 
stratify the data by regressing BMi on age, sex, center, and 
allele score and stratifying individuals based on their residual 
value from this regression. again, adjustment was made in 
the estimation of the causal effects for age, sex, and center. a 
more general sliding window approach was also used for esti-
mating localized average causal effects, initially for Hba1c, 
and then for all the outcomes. Figure 5 displays the estimates 
for Hba1c using window sizes of 500, 1,000, 1,500, 2,000, 
3,000, and 4,000. Figure 6 displays the estimates for all the 
outcomes using a window size of 2,000. For interpretability, 
the x-axis is the unstandardized BMi value corresponding to 
the BMi of the individual in the middle of the window. Previ-
ous work has shown that genetic associations with BMi are 
similar in extremely overweight individuals to those in the 
general population.27 to assess the assumption that the effect 
of the iV on BMi is similar across the exposure distribution, 
we estimated the association of the allele score with BMi in 
each of the quintiles of iV-free BMi. the association esti-
mates were 0.80, 1.02, 1.02, 0.98, 1.07; standard errors 0.08, 
0.03, 0.03, 0.04, 0.19; heterogeneity test P = 0.11; trend test 
P = 0.26. there is not sufficient evidence in this data set to 
reject this assumption.
the graphs showing localized average causal effect 
estimates for Hba1c demonstrate the trade-off in choosing a 
window size (Figure 5). With a smaller window size, there is 
increased detail in the estimate of the shape of the exposure–
outcome relation and estimates are obtained across a wider 
range of the exposure distribution. With a larger window size, 
precision of the estimates is increased. However, the possible 
threshold feature of the model, whereby the causal estimate is 
close to zero for low values of BMi, is lost as the window size 
increases. in addition, the shape of the graphs becomes closer 
to a straight line. it seems likely that much of the variabil-
ity in the estimates with a small window size reflects random 
fluctuation rather than interesting information, hence the use 
of a moderately large window size in Figure 6. estimates for 
total cholesterol and triglycerides show a similar pattern, with 
positive point estimates for median BMi levels less than 26, 
and estimates around or below zero for median BMi greater 
than 28. larger sample sizes are required for more definitive 
applied conclusions.
DISCUSSION
in this study, we have discussed the prospects for iV 
analyses with a nonlinear exposure–outcome relation. Spe-
cifically, we have provided an interpretation of linear iV esti-
mates in the presence of nonlinearity and have proposed a 
novel method to investigate whether causal effects depend on 
the level of the exposure.
Linear Estimation Approach
Simple linear iV estimators with a nonlinear exposure–
outcome relation estimate a parameter that approximates a 
population-averaged causal effect. this is the average effect 
resulting from an uniform increase in the exposure for all per-
sons in the population. However, the approximation may be 
poor for an iV with a large effect on the exposure and will 
break down if the population-averaged causal effect is con-
sidered for a change in the exposure much greater than that 
associated with the iV. if the exposure–outcome relation 
is monotonic (i.e., increasing or decreasing in the outcome 
for all values of the exposure), then the parameter estimated 
by a linear iV method will be in the same direction as the 
causal effect for each individual in the population. nonlin-
ear exposure–outcome relations should therefore not be seen 
as a barrier to iV analyses, such as Mendelian randomization 
investigations. However, if the exposure–outcome relation is 
not monotonic, a causal effect of the exposure on the outcome 
may be obscured by a linear iV estimate (potentially such as in 










Above 3  
Mean (SD)
linear  0.398 (0.179)  0.399 (0.167)  0.399 (0.267)  0.398 (0.377)
Quadratic  0.167 (0.173)  0.323 (0.165)  0.523 (0.272)  0.840 (0.524)
J-shaped  −0.065 (0.170)  0.247 (0.164)  0.647 (0.278)  1.282 (0.727)
U-shaped  −0.696 (0.165)  −0.230 (0.160)  0.371 (0.270)  1.323 (0.817)
threshold  −0.001 (0.169)  0.136 (0.163)  0.999 (0.293)  1.000 (0.512)
G X Y
X0 U
FIGURE 4. Directed  acyclic  graph  of  relationships  among 
instrumental variable (IV) G, exposure X, IV-free exposure X0, 
confounder U, and outcome Y.
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Parametric and Nonparametric Approaches
if the shape of the exposure–outcome relation is the sub-
ject of investigation, then a nonlinear parametric or nonpara-
metric iV analysis can be performed. inference from nonlinear 
parametric models has been previously shown to be sensitive 
to the choice of parametric model in a range of real scenar-
ios.22 inference from nonparametric models is limited when 
the iV does not explain much of the variation in the exposure. 
For example, the series method of newey and Powell19 is a 
2-stage nonparametric iV method. the first stage constructs 
a basis set of nonlinear functions (such as a set of orthogonal 
polynomials or B-splines) of the exposure conditional on the 
iV, and the second stage fits the outcome as a linear combina-
tion of these nonlinear functions. these estimates will not be 
reliable outside the range of the fitted values of the exposure 
conditional on the iV. Similar arguments can be made for the 
kernel and series methods of Hall and Horowitz.20
an alternative approach to nonlinear iV analysis is 
the quantile regression approach of chernozhukov and Han-











 Quintile 2 
Estimate (SE)
 Quintile 3 
Estimate (SE)
 Quintile 4 
Estimate (SE)
 Quintile 5 
Estimate (SE)
Systolic BP  0.35 (0.56)  0.42 (1.24)  1.19 (1.12)  0.44 (1.27)  −0.05 (1.20)  0.28 (1.35)  0.96  0.68
log crPa  7.41 (3.08)  1.01 (6.97) 22.52 (6.74)  −0.63 (6.65)  12.75 (6.02)  1.82 (6.22)  0.06 0.69
Uric acid  3.04 (1.97)  2.45 (4.11)  2.32 (4.04)  9.53 (4.19)  −1.47 (4.18)  1.65 (4.68)  0.45 0.75
Hba1ca  8.08 (2.02)  −0.85 (4.05)  4.89 (4.07)  6.40 (3.76)  13.14 (4.33)  12.90 (5.94)  0.14 0.08
total cholesterola −1.22 (3.13)  7.29 (6.77)  −6.32 (6.81)  10.70 (7.29)  −3.53 (7.05)  −11.89 (7.11)  0.13 0.28
log triglyceridesa  1.63 (1.45)  3.75 (2.93)  2.40 (3.09)  6.66 (3.13)  2.68 (3.15)  −7.44 (3.32)  0.03 0.17
acoefficients and standard errors are multiplied by 100 for presentation.
iV indicates instrumental variable; BMi, body mass index; BP, blood pressure; crP, c-reactive protein; Hba1c, glycated hemoglobin.





































































mass  index  from  EPIC-InterAct  data  set:  sliding  window 
approach with window sizes 500, 1,000, 1,500, 2,000, 3,000, 
and  4,000  (top-left  to  bottom-right).  Gray  lines  represent 
point wise 95% CIs.
























































































































Body mass index (kg/m²)
FIGURE 6. Localized average causal effect estimates of body 
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is that the unmeasured confounders can be represented by a 
single variable that has a monotone effect on the outcome.28 
this assumption is not only restrictive and unrealistic but 
also inherently unverifiable, and even sensitivity analyses 
to investigate the assumption cannot be performed. Such 
assumptions should not be relied on for identifying causal 
effects.
Localized Estimation Approach
By stratifying the population based on the iV-free 
exposure, localized average causal effects of the exposure on 
the outcome in each of the strata can reveal the shape of the 
exposure–outcome relation. in practice, such estimates in the 
strata may be imprecise, meaning that the true shape of the 
relation is obscured. this approach can be extended using a 
sliding window approach to provide a continuous estimate 
of the exposure–outcome relation across a wide range of the 
exposure distribution.
Unlike with other nonparametric iV approaches, this 
range widens as the sample size increases. either stratum-
specific or sliding window estimates can equally be estimated 
with a binary outcome by using a log-linear or logistic analy-
sis model to estimate a relative risk or odds ratio parameter. a 
localized average causal effect is simply an iV estimate esti-
mated for a particular stratum of the population as defined by 
the iV-free exposure. the same provisos about the approxima-
tion of an iV estimate to a population-averaged causal effect 
being valid only for small changes in the exposure and for iVs 
with a small effect on the exposure therefore apply equally for 
localized average causal effects.
Measurement Error
in observational analyses, coefficients in a linear regres-
sion model are affected by regression dilution bias if the 
exposure suffers from classical measurement error (ie, error 
uncorrelated with the true value of the exposure).29 estimates 
of the shape of nonlinear exposure–outcome relations can 
be distorted.30 in contrast, iV estimates under such an error 
model are unbiased.31 in the same way, since localized aver-
age causal effects are iV estimates for a given stratum of the 
population, the shape of relation estimated in a localized iV 
analysis will not be affected by classical measurement error 
in the exposure.
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